Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease

Taranjit Singh Rai, Madhu Khullar, B. S. Sehrawat, Monica Ahuja, Praveen Kumar Sharma, Rajesh Vijayvergiya, Anil Grover

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Alterations in lipid metabolism and genetic predisposition are major risk factors for coronary artery disease (CAD). Variations in genes involved in lipid metabolism may act synergistically to confer risk or protection against CAD. The objective of the present study was to determine such interactions in variants of apolipoprotein E and apolipoprotein A1 genes. One hundred and forty subjects with clinically confirmed CAD and 100 unrelated normal subjects participated in the study. Multiple regression analysis was used to relate lipid and apolipoprotein profiles with genotypes. Odd ratios were calculated for various combinations of ApoE and ApoA1 genotypes. Prevalence of ApoE 'E4' and ApoA1 'A' and 'T' alleles was significantly higher in patients than controls. Serum apolipoprotein E and apolipoprotein A1 levels were significantly lower in CAD patients than controls. When lipid parameters were related to genotypes, the polymorphisms associated to various markers were in agreement with previous reports. ApoE 2/4 genotype in combination with either ApoA1 heterozygous GA or CT genotype conferred higher risk of CAD. E3 allele in homozygous or heterozygous state in combination with ApoA1+83 CC genotype conferred highest protection (P < 0.05). Thus, it appears that ApoE and ApoA1 gene variants may act synergistically to associate with risk and protection against CAD.

LanguageEnglish
Pages139-146
Number of pages8
JournalMolecular and Cellular Biochemistry
Volume313
Issue number1-2
DOIs
Publication statusPublished - 1 Jun 2008

Fingerprint

Apolipoprotein A-I
Apolipoproteins E
Polymorphism
Coronary Artery Disease
Genes
Genotype
Lipid Metabolism
Alleles
Lipids
Apolipoproteins
Genetic Predisposition to Disease
Regression analysis
Odds Ratio
Regression Analysis
Serum

Keywords

  • ApoA1
  • ApoE
  • CAD
  • Diplotype
  • Genotype

Cite this

Rai, Taranjit Singh ; Khullar, Madhu ; Sehrawat, B. S. ; Ahuja, Monica ; Sharma, Praveen Kumar ; Vijayvergiya, Rajesh ; Grover, Anil. / Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease. In: Molecular and Cellular Biochemistry. 2008 ; Vol. 313, No. 1-2. pp. 139-146.
@article{09ac526255834459a2fab6cde58b79c7,
title = "Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease",
abstract = "Alterations in lipid metabolism and genetic predisposition are major risk factors for coronary artery disease (CAD). Variations in genes involved in lipid metabolism may act synergistically to confer risk or protection against CAD. The objective of the present study was to determine such interactions in variants of apolipoprotein E and apolipoprotein A1 genes. One hundred and forty subjects with clinically confirmed CAD and 100 unrelated normal subjects participated in the study. Multiple regression analysis was used to relate lipid and apolipoprotein profiles with genotypes. Odd ratios were calculated for various combinations of ApoE and ApoA1 genotypes. Prevalence of ApoE 'E4' and ApoA1 'A' and 'T' alleles was significantly higher in patients than controls. Serum apolipoprotein E and apolipoprotein A1 levels were significantly lower in CAD patients than controls. When lipid parameters were related to genotypes, the polymorphisms associated to various markers were in agreement with previous reports. ApoE 2/4 genotype in combination with either ApoA1 heterozygous GA or CT genotype conferred higher risk of CAD. E3 allele in homozygous or heterozygous state in combination with ApoA1+83 CC genotype conferred highest protection (P < 0.05). Thus, it appears that ApoE and ApoA1 gene variants may act synergistically to associate with risk and protection against CAD.",
keywords = "ApoA1, ApoE, CAD, Diplotype, Genotype",
author = "Rai, {Taranjit Singh} and Madhu Khullar and Sehrawat, {B. S.} and Monica Ahuja and Sharma, {Praveen Kumar} and Rajesh Vijayvergiya and Anil Grover",
year = "2008",
month = "6",
day = "1",
doi = "10.1007/s11010-008-9751-3",
language = "English",
volume = "313",
pages = "139--146",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
number = "1-2",

}

Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease. / Rai, Taranjit Singh; Khullar, Madhu; Sehrawat, B. S.; Ahuja, Monica; Sharma, Praveen Kumar; Vijayvergiya, Rajesh; Grover, Anil.

In: Molecular and Cellular Biochemistry, Vol. 313, No. 1-2, 01.06.2008, p. 139-146.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease

AU - Rai, Taranjit Singh

AU - Khullar, Madhu

AU - Sehrawat, B. S.

AU - Ahuja, Monica

AU - Sharma, Praveen Kumar

AU - Vijayvergiya, Rajesh

AU - Grover, Anil

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Alterations in lipid metabolism and genetic predisposition are major risk factors for coronary artery disease (CAD). Variations in genes involved in lipid metabolism may act synergistically to confer risk or protection against CAD. The objective of the present study was to determine such interactions in variants of apolipoprotein E and apolipoprotein A1 genes. One hundred and forty subjects with clinically confirmed CAD and 100 unrelated normal subjects participated in the study. Multiple regression analysis was used to relate lipid and apolipoprotein profiles with genotypes. Odd ratios were calculated for various combinations of ApoE and ApoA1 genotypes. Prevalence of ApoE 'E4' and ApoA1 'A' and 'T' alleles was significantly higher in patients than controls. Serum apolipoprotein E and apolipoprotein A1 levels were significantly lower in CAD patients than controls. When lipid parameters were related to genotypes, the polymorphisms associated to various markers were in agreement with previous reports. ApoE 2/4 genotype in combination with either ApoA1 heterozygous GA or CT genotype conferred higher risk of CAD. E3 allele in homozygous or heterozygous state in combination with ApoA1+83 CC genotype conferred highest protection (P < 0.05). Thus, it appears that ApoE and ApoA1 gene variants may act synergistically to associate with risk and protection against CAD.

AB - Alterations in lipid metabolism and genetic predisposition are major risk factors for coronary artery disease (CAD). Variations in genes involved in lipid metabolism may act synergistically to confer risk or protection against CAD. The objective of the present study was to determine such interactions in variants of apolipoprotein E and apolipoprotein A1 genes. One hundred and forty subjects with clinically confirmed CAD and 100 unrelated normal subjects participated in the study. Multiple regression analysis was used to relate lipid and apolipoprotein profiles with genotypes. Odd ratios were calculated for various combinations of ApoE and ApoA1 genotypes. Prevalence of ApoE 'E4' and ApoA1 'A' and 'T' alleles was significantly higher in patients than controls. Serum apolipoprotein E and apolipoprotein A1 levels were significantly lower in CAD patients than controls. When lipid parameters were related to genotypes, the polymorphisms associated to various markers were in agreement with previous reports. ApoE 2/4 genotype in combination with either ApoA1 heterozygous GA or CT genotype conferred higher risk of CAD. E3 allele in homozygous or heterozygous state in combination with ApoA1+83 CC genotype conferred highest protection (P < 0.05). Thus, it appears that ApoE and ApoA1 gene variants may act synergistically to associate with risk and protection against CAD.

KW - ApoA1

KW - ApoE

KW - CAD

KW - Diplotype

KW - Genotype

UR - http://www.scopus.com/inward/record.url?scp=44449179177&partnerID=8YFLogxK

U2 - 10.1007/s11010-008-9751-3

DO - 10.1007/s11010-008-9751-3

M3 - Article

VL - 313

SP - 139

EP - 146

JO - Molecular and Cellular Biochemistry

T2 - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -